TheProfitWatch

UNCY - Unicycive Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.6 0.18 (3.8%) --- --- --- -0.04 (-0.77%) 0.12 (2.47%) 0.05 (1.09%) -0.03 (-0.56%)

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.52
Diluted EPS:
-0.52
Basic P/E:
-9.1827
Diluted P/E:
-9.1827
RSI(14) 1m:
48.39
VWAP:
4.79
RVol:
0.684

Events

Period Kind Movement Occurred At
1m Price decrease 1m 4.78 -0.06 (-1.24%) Oct 15 10:08

Related News